Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Prana Biotechnology Shares Outstanding 2006-2018 | ATHE

Prana Biotechnology shares outstanding from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Prana Biotechnology Annual Shares Outstanding
(Millions of Shares)
2019 10
2018 9
2017 9
2016 9
2015 1
2014 7
2013 6
2012 5
2011 4
2010 4
2009 3
2008 3
2007 23
2006 21
2005 20
Prana Biotechnology Quarterly Shares Outstanding
(Millions of Shares)
Q2 2018
Q4 2018
Q2 2017
Q4 2017
Q2 2016
Q4 2016
Q2 2015
Q4 2015
Q2 2014
Q4 2014
Q2 2013
Q4 2013
Q2 2012
Q4 2012
Q2 2011
Q4 2011
Q2 2010
Q4 2010
Q2 2009
Q4 2009
Q2 2008
Q4 2008
Q2 2007
Q4 2007
Q2 2006
Q4 2006
Q2 2005
Q4 2005
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.015B $0.004B
Prana Biotechnology was established to commercialize research into Alzheimer's disease and other major age-related degenerative disorders. Their mission is to develop diagnostic and therapeutic drugs to treat the central disease pathways that cause degeneration of the brain as the aging process progresses. Prana's technology has emerged from its researchers at prominent international institutions such as Massachusetts General Hospital at Harvard Medical School and the University of Melbourne.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.342B 13.25
Gilead Sciences (GILD) United States $84.042B 10.32
CSL (CSLLY) Australia $72.428B 0.00
Celgene (CELG) United States $69.903B 10.81
Vertex Pharmaceuticals (VRTX) United States $44.326B 47.90
Illumina (ILMN) United States $43.735B 51.38
Biogen (BIIB) United States $42.849B 7.61
Regeneron Pharmaceuticals (REGN) United States $31.212B 14.17
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.275B 12.80
SINO PHARMACEUT (SBMFF) China $17.750B 0.00
Incyte (INCY) United States $16.360B 48.15
Exact Sciences (EXAS) United States $14.074B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.065B 0.00
Genmab (GNMSF) Denmark $12.366B 69.36
Seattle Genetics (SGEN) United States $11.463B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.123B 54.27
Alnylam Pharmaceuticals (ALNY) United States $9.249B 0.00
Galapagos (GLPG) Belgium $8.775B 0.00
QIAGEN (QGEN) Netherlands $7.685B 25.24
Bio-Techne Corp (TECH) United States $7.575B 52.33
Guardant Health (GH) United States $7.163B 0.00
Sarepta Therapeutics (SRPT) United States $6.540B 0.00
BeiGene (BGNE) Cayman Islands $6.319B 0.00
Amarin (AMRN) Ireland $5.983B 0.00
Exelixis (EXEL) United States $5.834B 15.16
Bluebird Bio (BLUE) United States $5.699B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.655B 0.00
Moderna (MRNA) United States $5.415B 0.00
Horizon Pharma Public (HZNP) Ireland $4.928B 12.53
ARGENX SE-ADR (ARGX) Netherlands $4.772B 0.00
Ascendis Pharma (ASND) Denmark $4.406B 0.00
Repligen (RGEN) United States $4.071B 79.01
Spark Therapeutics (ONCE) United States $4.066B 0.00
China Biologic Products (CBPO) China $3.934B 24.56
Blueprint Medicines (BPMC) United States $3.880B 0.00
Medicines (MDCO) United States $3.852B 0.00
MorphoSys AG (MOR) Germany $3.692B 0.00
Alkermes (ALKS) Ireland $3.554B 0.00
Mirati Therapeutics (MRTX) United States $3.329B 0.00
Immunomedics (IMMU) United States $3.018B 0.00
Emergent Biosolutions (EBS) United States $2.794B 41.97
Genomic Health (GHDX) United States $2.710B 50.82
CRISPR Therapeutics AG (CRSP) Switzerland $2.626B 0.00
Arena Pharmaceuticals (ARNA) United States $2.620B 5.63
Ultragenyx Pharmaceutical (RARE) United States $2.578B 0.00
Reata Pharmaceuticals (RETA) United States $2.564B 0.00
MyoKardia (MYOK) United States $2.541B 0.00
Amicus Therapeutics (FOLD) United States $2.493B 0.00
Acceleron Pharma (XLRN) United States $2.434B 0.00
Halozyme Therapeutics (HALO) United States $2.413B 0.00
NeoGenomics (NEO) United States $2.342B 125.28
Intercept Pharmaceuticals (ICPT) United States $2.226B 0.00
Myriad Genetics (MYGN) United States $2.040B 21.41
Cambrex (CBM) United States $2.010B 25.41
Zai Lab (ZLAB) China $1.964B 0.00
Akcea Therapeutics (AKCA) United States $1.957B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.863B 0.00
Ligand Pharmaceuticals (LGND) United States $1.855B 23.45
UniQure (QURE) Netherlands $1.838B 0.00
Denali Therapeutics (DNLI) United States $1.826B 0.00
Insmed (INSM) United States $1.696B 0.00
REGENXBIO (RGNX) United States $1.456B 0.00
Coherus BioSciences (CHRS) United States $1.391B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.369B 0.00
Alector (ALEC) United States $1.346B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.345B 0.00
Editas Medicine (EDIT) United States $1.292B 0.00
Sangamo Therapeutics (SGMO) United States $1.285B 0.00
RA PHARMCTL INC (RARX) United States $1.178B 0.00
Innoviva (INVA) United States $1.176B 3.39
AnaptysBio (ANAB) United States $1.159B 0.00
Fate Therapeutics (FATE) United States $1.141B 0.00
Epizyme (EPZM) United States $1.105B 0.00
Athenex (ATNX) United States $1.085B 0.00
Zymeworks (ZYME) Canada $1.022B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.016B 0.00
Twist Bioscience (TWST) United States $0.941B 0.00
Cara Therapeutics (CARA) United States $0.921B 0.00
Principia Biopharma (PRNB) United States $0.882B 459.75
Arvinas (ARVN) United States $0.879B 0.00
ANI Pharmaceuticals (ANIP) United States $0.877B 14.64
BAVARIAN NORDIC (BVNRY) Denmark $0.843B 0.00
Codexis (CDXS) United States $0.829B 0.00
WAVE Life Sciences (WVE) Singapore $0.826B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.815B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.771B 0.00
Anika Therapeutics (ANIK) United States $0.756B 26.76
Cytokineticsorporated (CYTK) United States $0.739B 0.00
Zealand Pharma (ZEAL) Denmark $0.734B 8.51
Vericel (VCEL) United States $0.729B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.727B 26.25
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Intellia Therapeutics (NTLA) United States $0.721B 0.00
Pharming Group (PHGUF) Netherlands $0.706B 0.00
Mesoblast (MESO) Australia $0.636B 0.00
DBV Technologies S.A (DBVT) France $0.578B 0.00
Intra-Cellular Therapies (ITCI) United States $0.577B 0.00
Revance Therapeutics (RVNC) United States $0.572B 0.00
MiMedx (MDXG) United States $0.561B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.557B 0.00
Cellectis S.A (CLLS) France $0.535B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
Precision BioSciences (DTIL) United States $0.506B 0.00
Retrophin (RTRX) United States $0.504B 0.00
Heska (HSKA) United States $0.500B 64.82
Autolus Therapeutics (AUTL) United Kingdom $0.498B 0.00
Syros Pharmaceuticals (SYRS) United States $0.492B 0.00
Stemline Therapeutics (STML) United States $0.480B 0.00
UROGEN PHARMA (URGN) United States $0.474B 0.00
PHARMA MAR SA (PHMMF) Spain $0.460B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.459B 0.00
Puma Biotechnology (PBYI) United States $0.451B 0.00
CytomX Therapeutics (CTMX) United States $0.440B 0.00
BioDelivery Sciences (BDSI) United States $0.424B 0.00
Agenus (AGEN) United States $0.422B 0.00
Arcus Biosciences (RCUS) United States $0.418B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.415B 0.00
Bellus Health (BLU) Canada $0.395B 0.00
Scholar Rock Holding (SRRK) United States $0.388B 0.00
Merus (MRUS) Netherlands $0.385B 0.00
Adverum Biotechnologies (ADVM) United States $0.384B 0.00
Protagonist Therapeutics (PTGX) United States $0.382B 0.00
Gritstone Oncology (GRTS) United States $0.365B 0.00
Kadmon Holdings (KDMN) United States $0.363B 0.00
AC Immune SA (ACIU) Switzerland $0.355B 26.25
Prothena (PRTA) Ireland $0.348B 0.00
Theratechnologies (THERF) Canada $0.325B 0.00
Biofrontera AG (BFRA) Germany $0.319B 477.09
Albireo Pharma (ALBO) United States $0.318B 0.00
Clovis Oncology (CLVS) United States $0.312B 0.00
ADMA Biologics Inc (ADMA) United States $0.310B 0.00
Dynavax Technologies (DVAX) United States $0.309B 0.00
Sorrento Therapeutics (SRNE) United States $0.304B 0.00
Avid Bioservices (CDMO) United States $0.304B 0.00
Geron (GERN) United States $0.298B 0.00
Starpharma Holdings (SPHRY) Australia $0.285B 0.00
Cellular Biomedicine (CBMG) United States $0.280B 0.00
Kindred Biosciences (KIN) United States $0.276B 0.00
MannKind (MNKD) United States $0.271B 0.00
PDL BioPharma (PDLI) United States $0.271B 6.97
Seres Therapeutics (MCRB) United States $0.270B 0.00
Prometic Life Sciences (PFSCF) Canada $0.266B 0.00
Inovio Pharmaceuticals (INO) United States $0.258B 0.00
Senesco Technologies (ELOX) United States $0.258B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.257B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.256B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.251B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.246B 0.00
Sutro Biopharma (STRO) United States $0.244B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.240B 0.00
Spero Therapeutics (SPRO) United States $0.232B 0.00
ChromaDex (CDXC) United States $0.231B 0.00
Athersys (ATHX) United States $0.226B 0.00
Five Prime Therapeutics (FPRX) United States $0.215B 0.00
Kamada (KMDA) Israel $0.213B 8.12
Compugen (CGEN) Israel $0.210B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.202B 0.00
Cue Biopharma (CUE) United States $0.199B 0.00
EXICURE INC (XCUR) United States $0.195B 0.00
Affimed (AFMD) Germany $0.195B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.191B 0.00
OSMOTICA PHARM (OSMT) United States $0.191B 0.00
Acorda Therapeutics (ACOR) United States $0.185B 0.00
Arsanis (XFOR) United States $0.184B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.182B 0.00
Enzo Biochem (ENZ) United States $0.170B 0.00
XOMA (XOMA) United States $0.168B 0.00
POXEL SA FRANCE (PXXLF) France $0.167B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Emmaus Life Sciences (EMMA) United States $0.163B 0.00
Northwest Biotherapeutics (NWBO) United States $0.163B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.162B 0.00
Nicox SA (NICXF) France $0.161B 0.00
Cerecor (CERC) United States $0.161B 0.00
Abeona Therapeutics (ABEO) United States $0.155B 0.00
Alcobra (ARCT) United States $0.152B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.148B 0.00
PHASEBIO PHARMA (PHAS) United States $0.147B 0.00
Strongbridge Biopharma (SBBP) United States $0.146B 6.00
Dyadic (DYAI) United States $0.142B 0.00
Adocia (ADOCY) France $0.140B 0.00
Novavax (NVAX) United States $0.137B 0.00
Aptinyx (APTX) United States $0.134B 0.00
NantKwest (NK) United States $0.131B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Fortress Biotech (FBIO) United States $0.128B 0.00
Menlo Therapeutics (MNLO) United States $0.126B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.109B 0.00
Aduro Biotech (ADRO) United States $0.107B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.106B 0.00
Celyad SA (CYAD) Belgium $0.099B 0.00
Verastem (VSTM) United States $0.097B 0.00
Mersana Therapeutics (MRSN) United States $0.096B 0.00
Arbutus Biopharma (ABUS) Canada $0.093B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
VTv Therapeutics (VTVT) United States $0.087B 0.00
Idera Pharmaceuticals (IDRA) United States $0.087B 0.00
Trevena (TRVN) United States $0.086B 0.00
Synlogic (SYBX) United States $0.083B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.081B 0.00
Antibe Therapeutics (ATBPF) Canada $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
OvaScience (MLND) United States $0.079B 0.00
Liquidia Technologies (LQDA) United States $0.077B 0.00
Catalyst Biosciences (CBIO) United States $0.077B 0.00
Orgenesis (ORGS) United States $0.074B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.073B 0.00
VBI Vaccines (VBIV) United States $0.072B 0.00
NewLink Genetics (NLNK) United States $0.072B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.068B 37.30
Curis (CRIS) United States $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.066B 0.00
ARAVIVE, INC (ARAV) United States $0.065B 0.00
AquaBounty Technologies (AQB) United States $0.065B 0.00
Pluristem Therapeutics (PSTI) Israel $0.063B 0.00
Unum Therapeutics (UMRX) United States $0.062B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.059B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
AIT Therapeutics (XAIR) United States $0.053B 0.00
Oncobiologics (OTLK) United States $0.049B 0.00
Ophthotech (ISEE) United States $0.049B 0.00
VistaGen Therapeutics (VTGN) United States $0.047B 0.00
Proteostasis Therapeutics (PTI) United States $0.047B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Evogene (EVGN) Israel $0.042B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.039B 0.00
Organovo Holdings (ONVO) United States $0.039B 0.00
Stellar Biotechnologies (EDSA) Canada $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
BIOCARDIA INC (BCDA) United States $0.033B 0.00
Signal Genetics (MGEN) United States $0.033B 0.00
AEterna Zentaris (AEZS) United States $0.031B 0.00
Entera Bio (ENTX) Israel $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Clearside Biomedical (CLSD) United States $0.029B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Apricus Biosciences (SEEL) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Aytu Bioscience (AYTU) United States $0.023B 0.00
TOCAGEN INC (TOCA) United States $0.022B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.10
Pulmatrix (PULM) United States $0.017B 0.00
Novogen (KZIA) Australia $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.015B 0.00
Novelion Therapeutics (NVLN) Canada $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00